Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04897334 · ClinicalTrials.gov registry record · NA

Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke

A NA study of Cognitive Impairment and Ischemic Stroke, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT04897334 is a NA study of Cognitive Impairment and Ischemic Stroke that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 70 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04897334, a NA study of Cognitive Impairment and Ischemic Stroke, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether a non-invasive brain stimulation technique, transcranial direct current stimulation (tDCS), combined with traditional cognitive therapy will improve cognitive function in patients with subacute stroke.

Interventions

  • DEVICE sham tDCS
  • DEVICE tDCS
  • BEHAVIORAL Cognitive Therapy

Study Locations (1)

Pennsylvania

  • Penn Medicine Rehabilitation - Philadelphia

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2021-09-21
Est. Completion 2028-01
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT04897334

The ClinicalTrials.gov registry entry for NCT04897334 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (89% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 3 interventions - of which sham tDCS is the first listed.

NCT04897334 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04897334 about?

NCT04897334 is a clinical study titled "Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke". The purpose of this study is to determine whether a non-invasive brain stimulation technique, transcranial direct current stimulation (tDCS), combined with traditional cognitive therapy will improve cognitive function in patients with subacute stroke.

What is the current status of trial NCT04897334?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2021-09-21. Estimated completion is 2028-01.

What conditions does trial NCT04897334 study?

This clinical trial studies the following conditions: Cognitive Impairment, Ischemic Stroke.

What interventions are being tested in trial NCT04897334?

The interventions under investigation include: sham tDCS (DEVICE), tDCS (DEVICE), Cognitive Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04897334?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04897334 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.